2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) …

IC Van Gelder, M Rienstra, KV Bunting… - European Heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

[HTML][HTML] Metabolic syndrome and atrial fibrillation: different entities or combined disorders

GE Zakynthinos, V Tsolaki, E Oikonomou… - Journal of Personalized …, 2023 - mdpi.com
Obesity, hypertension, insulin resistance, and dyslipidemia are all clusters of an entity called
“Metabolic Syndrome”. The global trends of this syndrome's incidence/prevalence continue …

The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists …

YH Chan, TF Chao, SW Chen, HF Lee, PR Li… - Cardiovascular …, 2022 - Springer
Background Although a few meta-analyses were conducted to compare the risk of incident
atrial fibrillation (AF) between sodium-glucose cotransporter-2 inhibitor (SGLT2i), glucagon …

Antidiabetic agents and risk of atrial fibrillation/flutter: a comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor …

AJ Scheen - Diabetes & Metabolism, 2022 - Elsevier
Atrial fibrillation/flutter (AF/AFL) is a common cardiac arrhythmia in patients with diabetes
and is associated with an increased risk of morbidity, including ischaemic stroke and heart …

Obesity as a risk factor for cardiac arrhythmias

KHK Patel, RK Reddy, A Sau… - BMJ …, 2022 - pmc.ncbi.nlm.nih.gov
Obesity is global health problem with an estimated three billion people worldwide being
classified as overweight or obese. In addition to being associated with a range of adverse …

[HTML][HTML] The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review

P Stachteas, A Nasoufidou, E Karagiannidis… - Journal of Clinical …, 2024 - mdpi.com
Atrial fibrillation (AF) is the most prevalent arrhythmia among adults worldwide, frequently co-
occurring with comorbidities such as Heart Failure (HF) and Type 2 Diabetes Mellitus …

[HTML][HTML] Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-κB-dependent cardiomyocyte pyroptosis

C Lv, C Hu, C Zhu, X Wan, C Chen, X Ji, Y Qin… - Biomedicine & …, 2024 - Elsevier
Autoimmune myocarditis, which falls within the broad spectrum of myocarditis, is
characterized by an excessive inflammatory response in the heart, and can progress into …

[HTML][HTML] Meeting at the crossroad between obesity and hepatic carcinogenesis: unique pathophysiological pathways raise expectations for innovative therapeutic …

K Arvanitakis, SP Papadakos, V Lekakis… - International Journal of …, 2023 - mdpi.com
The escalating global prevalence of obesity and its intricate association with the
development of hepatocellular carcinoma (HCC) pose a substantial challenge to public …

Association between the systemic immune‐inflammation index and outcomes among atrial fibrillation patients with diabetes undergoing radiofrequency catheter …

Z Zhao, B Jiang, F Zhang, R Ma, X Han, C Li… - Clinical …, 2023 - Wiley Online Library
Purpose To investigate the relationship between the incidence of atrial fibrillation (AF)
recurrence and the levels of the systemic immune‐inflammatory index (SII, platelet× …

Prediabetes as a risk factor for new-onset atrial fibrillation: The propensity-score matching cohort analyzed using the Cox regression model coupled with the random …

JC Hsu, YY Yang, SL Chuang, LY Lin… - Cardiovascular …, 2023 - Springer
Background The glycemic continuum often indicates a gradual decline in insulin sensitivity
leading to an increase in glucose levels. Although prediabetes is an established risk factor …